1. Recurring pathogenic variants in the BRCA2 gene in the Ethiopian Jewish population. Founder mutations?

   • Mark D. Ludman
   • Shira Litz Philipsborn
   • Eyal Reinstein

   Letter to the Editor 15 February 2022 Pages: 121 - 123

2. Questioning the validity of clinically available breast cancer polygenic risk scores: comparison of two labs reveals discrepancies

   • Julia Wynn
   • Elana Levinson
   • Wendy K. Chung

   Letter to the Editor 18 May 2021 Pages: 125 - 127

3. Extended gene panel testing in lobular breast cancer

   • Elke M. van Veen
   • D. Gareth Evans
   • Miriam J. Smith

   Original Article Open access 25 March 2021 Pages: 129 - 136

4. A comprehensive reference for BRCA1/2 genes pathogenic variants in Iran: published, unpublished and novel

   • Keivan Majidzadeh-A
   • Shiva Zarinfam
   • Mohamad Zamani

   Original Article 23 March 2021 Pages: 137 - 142

5. “I wish that there was more info”: characterizing the uncertainty experienced by carriers of pathogenic ATM and/or CHEK2 variants

   • Kathryn G. Reyes
   • Cheyla Clark
   • Kelly E. Ormond

   Original Article 15 April 2021 Pages: 143 - 155

6. Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients

   • Bettina Meiser
   • Paula Woodward
   • Kathy Tucker

   Original Article 10 May 2021 Pages: 157 - 166

   

7. Adaptation and early implementation of the PREdiction model for gene mutations (PREMM₅™) for lynch syndrome risk assessment in a diverse population

   • Kathleen F. Mittendorf
   • Chinedu Ukaegbu
   • Katrina A. B. Goddard

   Original Article Open access 23 March 2021 Pages: 167 - 180

   

8. A novel founder MSH2 deletion in Ethiopian Jews is mainly associated with early-onset colorectal cancer

   • I. Kedar
   • L. Walsh
   • Y. Goldberg

   Original Article 10 April 2021 Pages: 181 - 188

   

9. Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators

   • Muhammad Salman Faisal
   • Carol A. Burke
   • Gautam Mankaney

   Original Article 06 April 2021 Pages: 189 - 195

   

10. The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management

    • Claire Palles
    • Lynn Martin
    • Andrew Latchford

    Original Article Open access 05 May 2021 Pages: 197 - 209

    

11. First international workshop of the ATM and cancer risk group (4-5 December 2019)

    • Fabienne Lesueur
    • Douglas F. Easton
    • Nadine Andrieu

    Review 14 June 2021 Pages: 211 - 227

12. Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings

    • Ioana Fugaru
    • Catherine Goudie
    • John-Paul Capolicchio

    Short Communication 20 April 2021 Pages: 229 - 233

    

13. CDH1 pathogenic variants and cancer risk in an unselected patient population

    • Ariel Bar-Mashiah
    • Emily R. Soper
    • Noura S. Abul-Husn

    Short Communication 22 April 2021 Pages: 235 - 239

14. The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1

    • Ashley Crook
    • Rebekah Kwa
    • Yemima Berman

    Original Article 08 May 2021 Pages: 241 - 253